Maitreya Medicare (NSE:MAITREYA) Interest Expense : ₹-3.1 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Maitreya Medicare Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Maitreya Medicare's interest expense for the six months ended in Sep. 2023 was ₹ -3.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-3.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Maitreya Medicare's Operating Income for the six months ended in Sep. 2023 was ₹ 50.5 Mil. Maitreya Medicare's Interest Expense for the six months ended in Sep. 2023 was ₹ -3.1 Mil. Maitreya Medicare's Interest Coverage for the quarter that ended in Sep. 2023 was 16.09. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Maitreya Medicare Interest Expense Historical Data

The historical data trend for Maitreya Medicare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maitreya Medicare Interest Expense Chart

Maitreya Medicare Annual Data

Trend

Mar21

Mar22

Mar23

Interest Expense

-6.34

-6.06

-5.65

Maitreya Medicare Semi-Annual Data
	Mar21	Mar22	Mar23	Sep23
Interest Expense	-	-	-	-3.14

Maitreya Medicare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-3.1 Mil.

Maitreya Medicare (NSE:MAITREYA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Maitreya Medicare's Interest Expense for the six months ended in Sep. 2023 was ₹-3.1 Mil. Its Operating Income for the six months ended in Sep. 2023 was ₹50.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was ₹39.2 Mil.

Maitreya Medicare's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2023 )	/	Interest Expense (Q: Sep. 2023 )
	=	-1	*	50.546	/	-3.141
	=	16.09

The higher the ratio, the stronger the company's financial strength is.

Maitreya Medicare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Maitreya Medicare Ltd (NSE:MAITREYA) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007

Website

https://www.maitreyahospitals.com

Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.

Maitreya Medicare Headlines

No Headlines